Chang Liu

机构：Hebei Medical University, Weifang Medical University, Guangdong Academy of Sciences, Fuzhou Second Hospital, First Hospital of China Medical University, Qilu Hospital of Shandong University, Zhejiang University, China Medical University · ORCID：0000-0003-0776-6984

发表论文 37 篇 · 总被引 1040 次 · h-index 16

代表论文

• TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer (2022 · Journal of Experimental & Clinical Cancer Research · 被引 171)
• Astrocyte-derived lactate aggravates brain injury of ischemic stroke in mice by promoting the formation of protein lactylation (2024 · Theranostics · 被引 109)
• Global burden and future trends of metabolic dysfunction-associated Steatotic liver disease: 1990-2021 to 2045 (2025 · Annals of Hepatology · 被引 56)
• Ameliorative effects of chlorogenic acid on alcoholic liver injury in mice via gut microbiota informatics (2022 · European Journal of Pharmacology · 被引 52)
• Blockade of CCR5 suppresses paclitaxel-induced peripheral neuropathic pain caused by increased deoxycholic acid (2023 · Cell Reports · 被引 27)
• Long-term modification of gut microbiota by broad-spectrum antibiotics improves stroke outcome in rats (2022 · Stroke and Vascular Neurology · 被引 27)